Regeneron logo

Field Reimbursement Manager - Neurology (South Central)

Regeneron
June 27, 2026
On-site
Houston, TX
Market Access
Field role (Dallas/Houston, Metro TX).

Responsibilities:
- Develop and execute account-specific access and reimbursement plans to support product launch, optimize site of care, build reimbursement confidence, and support continued patient access.
- Educate accounts on patient support services; collaborate with Patient Services for patient onboarding, therapy initiation, and ongoing treatment.
- Partner with Sales, Patient Services, Account Directors, and Medical to align access strategy and remove barriers to therapy initiation.
- Ensure consistent, accurate REMS communication and field execution.
- Coordinate between provider offices, specialty pharmacy, and infusion sites.
- Guide HCPs resolving access challenges (prior authorizations, denials, appeals, and payer site-of-care restrictions) per company policies.
- Anticipate/adapt to evolving launch dynamics, payer policies, and distribution pathway changes.
- Manage time and efficiently cover the assigned FRM territory.
- Build relationships with access champions to support access readiness and ongoing delivery.
- Update customers on payer policy evolution, coding updates (e.g., J-code progression), and site-of-care management.

Qualifications:
- Bachelor’s degree and 5+ years in biopharma reimbursement/market access/field-based access roles in a matrix environment; 2+ years direct reimbursement experience for medical benefit therapies (buy & bill preferred).
- Experience across buy & bill and specialty pharmacy models, including white bagging and site-of-care management.
- Rare disease experience and product launch experience strongly preferred.

Application instructions:
- Apply now.

Benefits (as stated): health/wellness programs (medical, dental, vision, life, disability), fitness centers, 401(k) match, family support, equity awards, annual bonuses, paid time off, and paid leaves.

Salary range (annually): $165,600.00–$209,600.00.